肝细胞癌的表观遗传变化:机制,生物标志物和治疗影响
Adil Farooq Wali1, Abid Reza Ansari2, Prince Ahad Mir3
1RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.
诸如DNA甲基化和非编码RNA (ncRNA) 失调等表观遗传变化是肝细胞癌 (HCC) 的关键驱动因素. 针对这些可逆的修改为肝癌提供了新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 是一种主要的肝癌,死亡率高.
- 遗传和表观遗传因素都有助于HCC的发展和进展.
- 表观遗传异常,包括DNA甲基化,基因组修饰,染色质重塑和ncRNA失调,在HCC中至关重要.
研究的目的:
- 审查最近在HCC的表观遗传景观上的进展.
- 讨论HCC.中的表观遗传修饰的诊断和治疗影响.
- 突出表观遗传学的潜力,通过个性化医学改善患者的治疗结果.
主要方法:
- 审查当前关于HCC.表观遗传修饰的文献.
- 分析特定的miRNAs (例如,miR-375,miR-483-5p) 和表观遗传特征 (例如,CDH1促进剂高甲基化,HOTAIR过度表达) 的作用.
- 讨论表观遗传点的诊断和治疗潜力.
主要成果:
- 特定miRNAs (miR-375,miR-483-5p) 的失调与HCC阶段和患者存活率密切相关.
- 表观遗传修饰是可逆的,提供了有前途的治疗机会.
- 像CDH1高甲基化和HOTAIR过度表达这样的表观遗传特征显示出早期检测和治疗反应的生物标志物的潜力.
结论:
- 表观遗传异常在HCC的发病和进展中起着重要作用.
- 可逆表观遗传修饰为HCC提供了可行的治疗点.
- 表观遗传生物标志物和疗法对个性化医疗方法在HCC管理中具有前景.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Specific Gene Expression
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
